DRIEHAUS CAPITAL MANAGEMENT LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 33 filers reported holding MIRATI THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$247,000
-99.1%
3,000
-98.4%
0.00%
-98.9%
Q4 2021$26,910,000
+2.2%
183,446
+23.3%
0.28%
-11.9%
Q3 2021$26,329,000
+158.4%
148,827
+135.9%
0.31%
+131.1%
Q2 2021$10,191,000
-35.3%
63,091
-31.4%
0.14%
-41.8%
Q1 2021$15,756,000
-30.2%
91,981
-10.5%
0.23%
-36.4%
Q4 2020$22,583,000
+25.6%
102,817
-5.0%
0.36%
-1.1%
Q3 2020$17,978,000
+52.7%
108,266
+5.0%
0.37%
+29.0%
Q2 2020$11,772,000
+50.5%
103,108
+1.3%
0.29%
+9.6%
Q1 2020$7,822,000
-42.4%
101,755
-3.4%
0.26%
-27.7%
Q4 2019$13,570,000
-9.3%
105,305
-45.2%
0.36%
-25.9%
Q3 2019$14,960,000
-47.6%
192,017
-30.8%
0.49%
-45.6%
Q2 2019$28,572,000
+101.2%
277,396
+43.2%
0.90%
+67.9%
Q1 2019$14,202,000
+46.3%
193,751
-15.3%
0.53%
+28.4%
Q4 2018$9,705,000
-47.2%
228,775
-41.3%
0.42%
-26.5%
Q3 2018$18,368,000
-15.6%
389,977
-11.7%
0.56%
-23.2%
Q2 2018$21,764,000
+712.4%
441,470
+252.7%
0.74%
+746.0%
Q1 2016$2,679,000
-52.0%
125,178
-29.1%
0.09%
-53.7%
Q4 2015$5,577,000
+7.4%
176,473
+17.0%
0.19%
+0.5%
Q3 2015$5,191,000
+26.8%
150,812
+16.0%
0.19%
+31.7%
Q2 2015$4,093,000
+51.8%
130,046
+41.4%
0.14%
+52.7%
Q1 2015$2,696,000
+57.5%
91,942
-0.5%
0.09%
+34.8%
Q4 2014$1,712,000
+8.4%
92,432
+2.5%
0.07%
+15.0%
Q3 2014$1,579,000
-51.8%
90,188
-44.9%
0.06%
-43.4%
Q2 2014$3,274,000
-27.9%
163,675
-31.2%
0.11%
-25.9%
Q1 2014$4,539,000238,0300.14%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders